MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Health Systems, Economic Evaluations, Quality of Life
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

6,862 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
6,862 works in the cohort · of 4,299,418page 28 of 138

Labels cover 97 of 6,862 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 6,862 of 6,862 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Improving transparency to build trust in <scp>real‐world</scp> secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the <scp>real‐world</scp> evidence transparency initiative
Lucinda Orsini, Brigitta U. Monz, C. Daniel Mullins, David Van Brunt, Gregory W. Daniel, Hans‐Georg Eichler +10 more
2020· article· en· Pharmacoepidemiology and Drug Safety· Economics, Econometrics and Finance
machine prediction:candidate · metaresearchconsensus · metaresearch
25
citations
affno abstractunlabeled
The End of the Risk–Treatment Paradox?
Finlay A. McAlister
2011· letter· en· Journal of the American College of Cardiology· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
25
citations
affunlabeled
Moving forward on rationing: an economic view
Cam Donaldson, Angela Bate, Peter Brambleby, Howard Waldner
2008· article· en· BMJ· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
25
citations
affunlabeled
ESMO Guidance for Reporting Oncology real-World evidence (GROW)
Luís Castelo-Branco, Anna Pellat, Diogo Martins-Branco, Antonios Valachis, Jeroen W. G. Derksen, Karijn P.M. Suijkerbuijk +17 more
2023· article· en· ESMO Real World Data and Digital Oncology· Economics, Econometrics and Finance
machine prediction:candidate · metaresearchconsensus · none
25
citations
affaboutunlabeled
Assessment of Back-Related Quality of Life
Sharon Wood-Dauphinée
2001· article· en· Spine· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
25
citations
fundno affunlabeled
Exclusion Criteria as Measurements II: Effects on Utility Functions
Barry Dewitt, Baruch Fischhoff, Alexander Davis, Stephen B. Broomell, Mark S. Roberts, Janel Hanmer
2019· article· en· Medical Decision Making· Economics, Econometrics and Finance
machine prediction:candidate · metaresearchconsensus · none
25
citations
affno abstractunlabeled
Economic evaluation in critical care medicine
Heather L. Cox, Kevin B. Laupland, Braden Manns
2006· article· en· Journal of Critical Care· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
25
citations
affno abstractunlabeled
ISPOR Code of Ethics 2017 (4th Edition)
Jéssica Cristina Pereira Santos, Francis B. Palumbo, Elizabeth Molsen-David, Richard J. Willke, Louise Binder, Michael Drummond +6 more
2017· article· en· Value in Health· Economics, Econometrics and Finance
machine prediction:candidate · research_integrityconsensus · none
25
citations
affvenueunlabeled
Updating the OMERACT Filter: Discrimination and Feasibility
George A. Wells, Dorcas Beaton, Peter Tugwell, Maarten Boers, John Kirwan, Clifton O. Bingham +19 more
2014· article· en· The Journal of Rheumatology· Economics, Econometrics and Finance
machine prediction:candidate · metaresearchconsensus · none
25
citations
afffundunlabeled
Prioritisation and design of clinical trials
Anna Heath, M. G. Myriam Hunink, Eline Krijkamp, Petros Pechlivanoglou
2021· article· en· European Journal of Epidemiology· Economics, Econometrics and Finance
machine prediction:candidate · metaresearchconsensus · none
24
citations

How this was built: Screen · Findings · About